Search research articles
Contact Us
Filters
Showing results (271-280 of 531) with videos related to
Page
of 54
Sort By:
Antimicrobial Agents and Chemotherapy
|
April 8, 2009
In vitro activity of ceftaroline alone and in combination against clinical isolates of resistant gram-negative pathogens, including beta-lactamase-producing Enterobacteriaceae and Pseudomonas aeruginosa
Céline Vidaillac, Steve N Leonard, Helio S Sader, et al.
Antimicrobial Agents and Chemotherapy
|
March 14, 2018
Combination of Tedizolid and Daptomycin against Methicillin-Resistant Staphylococcus aureus in an <i>In Vitro</i> Model of Simulated Endocardial Vegetations
Jordan R Smith, Juwon Yim, Seth Rice, et al.
Antimicrobial Agents and Chemotherapy
|
February 14, 2007
Fluoroquinolone resistance in Streptococcus pneumoniae: area under the concentration-time curve/MIC ratio and resistance development with gatifloxacin, gemifloxacin, levofloxacin, and moxifloxacin
Kerry L LaPlante, Michael J Rybak, Brian Tsuji, et al.
Infectious Diseases and Therapy
|
July 20, 2016
Evaluation of Pharmacodynamic Interactions Between Telavancin and Aztreonam or Piperacillin/Tazobactam Against Pseudomonas aeruginosa, Escherichia coli and Methicillin-Resistant Staphylococcus aureus
Juwon Yim, Jordan R Smith, Katie E Barber, et al.
Diagnostic Microbiology and Infectious Disease
|
February 9, 2005
Clinical isolates of Staphylococcus aureus from 1987 and 1989 demonstrating heterogeneous resistance to vancomycin and teicoplanin
Michael J Rybak, Raymond Cha, Chrissy M Cheung, et al.
The Journal of Antimicrobial Chemotherapy
|
November 30, 2014
Comment on: Failure of combination therapy with daptomycin and synergistic ceftriaxone for enterococcal endocarditis
Ashley Hall Snyder, Brian J Werth, Katie E Barber, et al.
Wiadomosci Lekarskie (Warsaw, Poland : 1960)
|
March 1, 1978
[Acute complications of neoplasms of the large bowel]
Z Puchalski, Z Piotrowski, J Okulczyk, et al.
Antimicrobial Agents and Chemotherapy
|
March 28, 1998
Comparative in vitro activities and postantibiotic effects of the oxazolidinone compounds eperezolid (PNU-100592) and linezolid (PNU-100766) versus vancomycin against Staphylococcus aureus, coagulase-negative staphylococci, Enterococcus faecalis, and Enterococcus faecium
M J Rybak, D M Cappelletty, T Moldovan, et al.
Infectious Diseases and Therapy
|
December 19, 2014
Evaluation of High-Dose Daptomycin Versus Vancomycin Alone or Combined with Clarithromycin or Rifampin Against Staphylococcus aureus and S. epidermidis in a Novel In Vitro PK/PD Model of Bacterial Biofilm
Ashley D Hall Snyder, Celine Vidaillac, Warren Rose, et al.
Pharmacotherapy
|
April 13, 2023
Sulbactam-durlobactam: A novel β-lactam-β-lactamase inhibitor combination targeting carbapenem-resistant Acinetobacter baumannii infections
Amer El-Ghali, Ashlan J Kunz Coyne, Kaylee Caniff, et al.
Page
of 54
Search research articles
Search
Showing results (271-280 of 531) with videos related to
Sort By:
Page
of 54
Antimicrobial Agents and Chemotherapy
|
April 8, 2009
In vitro activity of ceftaroline alone and in combination against clinical isolates of resistant gram-negative pathogens, including beta-lactamase-producing Enterobacteriaceae and Pseudomonas aeruginosa
Céline Vidaillac, Steve N Leonard, Helio S Sader, et al.
Antimicrobial Agents and Chemotherapy
|
March 14, 2018
Combination of Tedizolid and Daptomycin against Methicillin-Resistant Staphylococcus aureus in an <i>In Vitro</i> Model of Simulated Endocardial Vegetations
Jordan R Smith, Juwon Yim, Seth Rice, et al.
Antimicrobial Agents and Chemotherapy
|
February 14, 2007
Fluoroquinolone resistance in Streptococcus pneumoniae: area under the concentration-time curve/MIC ratio and resistance development with gatifloxacin, gemifloxacin, levofloxacin, and moxifloxacin
Kerry L LaPlante, Michael J Rybak, Brian Tsuji, et al.
Infectious Diseases and Therapy
|
July 20, 2016
Evaluation of Pharmacodynamic Interactions Between Telavancin and Aztreonam or Piperacillin/Tazobactam Against Pseudomonas aeruginosa, Escherichia coli and Methicillin-Resistant Staphylococcus aureus
Juwon Yim, Jordan R Smith, Katie E Barber, et al.
Diagnostic Microbiology and Infectious Disease
|
February 9, 2005
Clinical isolates of Staphylococcus aureus from 1987 and 1989 demonstrating heterogeneous resistance to vancomycin and teicoplanin
Michael J Rybak, Raymond Cha, Chrissy M Cheung, et al.
The Journal of Antimicrobial Chemotherapy
|
November 30, 2014
Comment on: Failure of combination therapy with daptomycin and synergistic ceftriaxone for enterococcal endocarditis
Ashley Hall Snyder, Brian J Werth, Katie E Barber, et al.
Wiadomosci Lekarskie (Warsaw, Poland : 1960)
|
March 1, 1978
[Acute complications of neoplasms of the large bowel]
Z Puchalski, Z Piotrowski, J Okulczyk, et al.
Antimicrobial Agents and Chemotherapy
|
March 28, 1998
Comparative in vitro activities and postantibiotic effects of the oxazolidinone compounds eperezolid (PNU-100592) and linezolid (PNU-100766) versus vancomycin against Staphylococcus aureus, coagulase-negative staphylococci, Enterococcus faecalis, and Enterococcus faecium
M J Rybak, D M Cappelletty, T Moldovan, et al.
Infectious Diseases and Therapy
|
December 19, 2014
Evaluation of High-Dose Daptomycin Versus Vancomycin Alone or Combined with Clarithromycin or Rifampin Against Staphylococcus aureus and S. epidermidis in a Novel In Vitro PK/PD Model of Bacterial Biofilm
Ashley D Hall Snyder, Celine Vidaillac, Warren Rose, et al.
Pharmacotherapy
|
April 13, 2023
Sulbactam-durlobactam: A novel β-lactam-β-lactamase inhibitor combination targeting carbapenem-resistant Acinetobacter baumannii infections
Amer El-Ghali, Ashlan J Kunz Coyne, Kaylee Caniff, et al.
Page
of 54